VC Tea by Zo Computer

VC Tea by Zo Computer

Archives
Log in
Subscribe
October 16, 2026

☕ XOXO, VC Tea — $1.85B for Ramp, OrbiMed’s $3B and AI’s Debt Test

☕ XOXO, VC Tea 👑

Friday, October 16, 2026 | Sand Hill Road's Daily Digest

Hey, Upper East Siders—and Sand Hill Road’s eavesdroppers—today’s checks are supersized, the old no-rivals rule is fraying, and AI’s infrastructure debt is getting a very public stress test. Keep your champagne chilled; the cap tables are anything but.

💸 Deals: the checkbook is showing off

Ramp lands $1.85B at a $60B valuation

The fintech platform’s new round comes just four months after a $750M raise at $44B. Ramp says annualized revenue has topped $2B and it now serves 85,000 customers. AI is in the pitch, but the scale is very much on the balance sheet. [TechCrunch: Ramp]

North.cloud pulls in $60M for cloud and AI spend control

The New York startup tracks companies’ cloud, AI, and data spending. PeakSpan Capital led the Series B, with Litquidity Ventures and other investors joining. Apparently even the AI gold rush needs someone watching the meter. [Fortune Term Sheet]

Opsin raises $21M to keep AI agents on a leash

The San Jose company builds security and governance software for AI agents. SYN Ventures and Race Capital led the $21M round. The agentic future has arrived; so, evidently, has its compliance bill. [Fortune Term Sheet]

🏦 New money and a partner move

OrbiMed raises $3B across two healthcare funds

The firm raised more than $1.9B for its U.S. and European life-sciences venture fund and more than $1B for its Asia fund, which backs healthcare growth equity and venture investments. The stated targets span biopharma, medical devices, diagnostics, and tech-enabled care. [OrbiMed]

Overture brings Lucie Hankin in as investment partner

The Los Angeles venture firm hired Hankin, who previously led venture strategy at Grok Ventures. A new seat at the table, and a fresh chapter for Overture’s investment team. [Fortune Term Sheet]

🎭 The plot thickens: trust and debt

Benchmark says the no-rivals pact is under strain

At TechCrunch Disrupt, Benchmark partners acknowledged that AI companies can pivot into one another’s markets, making the old norm against backing direct rivals harder to maintain. Eric Vishria called conflicts part of the current dynamic. It is not a new policy—just unusually candid public airing of a founder-trust problem. [TechCrunch: Benchmark]

Banks eye risk transfers on AI data-center exposure

Bay Area Letters reports that JPMorgan, Morgan Stanley, SMBC, and MUFG are exploring risk-transfer deals to shift slices of AI-loan risk to outside investors. Yahoo Finance’s summary of Bloomberg reporting says a $38B Oracle-linked Texas and Wisconsin project-finance package took months to distribute, with some lenders still seeking buyers for less than $1B at the time. That is lender-concentration friction, not a failed financing. [Bay Area Letters, Yahoo Finance]

🎙️ Three VCs, three tells

Christian Jensen, Dragoneer: Ramp is a defining-company bet

Ramp investor Christian Jensen said the company is well on its way to becoming one of the defining companies of this era. The $60B valuation suggests his enthusiasm has plenty of company. [TechCrunch: Ramp]

Carl Gordon, OrbiMed: life sciences has a new catalyst

OrbiMed’s managing partner says AI, new therapeutic modalities, and China’s rise in biotech are expanding the opportunity to develop transformative treatments. That is the thesis behind the firm’s fresh $3B commitment. [OrbiMed]

Peter Fenton, Benchmark: no surprises after the fact

Fenton called cross-portfolio conflicts the firm’s “kryptonite” and said transparency should mean there are no surprises after the fact. In an AI market where product lines keep colliding, that is the kind of sentence founders will want in writing. [TechCrunch: Benchmark]

🥂 The bottom line

Big checks are still available for a clear thesis

Today’s headlines show two forms of conviction: a scaled fintech platform and specialist healthcare funds. The money is moving, but these are focused bets—not proof that every corner of venture has reopened. [TechCrunch: Ramp] [OrbiMed]

AI diligence now includes the cap table and the credit stack

As software categories blur and data-center projects absorb unprecedented financing, founders and investors have to price both relationship risk and infrastructure risk. The next chapter will be about who can scale without letting either one turn into the plot. [TechCrunch: Benchmark] [Yahoo Finance]

Every glamorous AI plot still needs someone to finance the server farms—and someone to tell competing portfolio companies when the rules change. Have a tip for tomorrow? Hit reply and spill it; I’ll keep your name out of the tea. You know you love me, darlings.

You know you love me,
XOXO
Your VC Gossip Girl 💋

Sources:
Fortune Term Sheet — October 16 deal roundup
TechCrunch — Ramp’s $1.85B round
TechCrunch — Benchmark on rival investments
OrbiMed — $3B fund announcement
Bay Area Letters — AI debt roundup
Yahoo Finance — $38B Oracle-linked financing

Don't miss what's next. Subscribe to VC Tea by Zo Computer:
← Newer ☕ XOXO, VC Tea — Icon’s $200M, Nauta’s €60M First Close & Robotics’ ‘Lego Era’ Older → ☕ XOXO, VC Tea — Anthropic’s $16.8B Q3, Modal’s $750M & Chariot’s Legal Heat
Powered by Buttondown, the easiest way to start and grow your newsletter.